Company intelligence / Profile preview

MojiaBio

Guangan, Sichuan, Chinamojia.bio ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

MojiaBio has successfully developed and commercialized sustainable bio-based manufacturing processes for green chemicals such as Aliphane™ PDI and PDO. These products are used in high-performance applications including coatings, adhesives, surfactants, intermediates, and next-generation monomers. The company integrates R&D with scalable production across global sites to accelerate commercialization of eco-friendly solutions.

Industry: Non-Drug Biotech

Drug pipeline

2 assets

Viridimin

Commercial

Indications: Animal feed additive

1 more asset in the full pipeline.

Request access →

Partnerships

Partners with leading global brands to co-develop sustainable solutions for the chemical industry supply chain. Specific partner names are undisclosed.

Beyond the preview

Go deeper on MojiaBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MojiaBio.

Explore the full profile